Search

Find exactly what you’re looking for.
Search

Showing 1-7 of 7 results

Antitrust significantly impacts commercial business throughout the United States – from monopoly lawsuits against Big Tech to horizontal price-fixing cases to the development of antitrust compliance programs for start-ups. Irrespective of size, businesses must comply with antitrust laws, trade...

Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...

Navigating Issues Unique to the Independent School Landscape In addition to independent schools’ core educational missions, they must balance a host of business and legal needs in order to prudently manage their endowments, admissions, and enrollment priorities and to hire and retain top-quality...

Tailored Guidance for Independent and Charter Schools While independent and charter K-12 schools experience many of the same challenges as public schools, they are unique. Charter schools must submit charter school applications and comply with state and federal charter school laws. Independent...

In response to the ongoing challenges to their profits, pharmaceutical and other life sciences companies continue to outsource many specialized services. From R&D to manufacturing – and everything in between – opportunities abound for companies that have the knowledge and expertise to effectively...

Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...

Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...

For More Information
Contact us